PATENT CLAIM ANALYSIS

Application Number: 15750583
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-05
Patent Classification: ["514", "063000"]

Abstract:
The present invention provides a compound of general formula (I) (wherein, R 1 , X, p and q are as described in the present description and claims), or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing that compound.

Claim (Index 7):
The compound according to  claim 6 , or a pharmacologically acceptable salt thereof, wherein\n R 1  represents a hydrogen atom, optionally substituted C 1 -C 6  alkyl group, C 2 -C 6  alkenyl group, optionally substituted C 3 -C 8  cycloalkyl group, optionally substituted C 1 -C 6  alkoxy-C 1 -C 6  alkyl group or optionally substituted heterocyclyl group, wherein, the term \u201csubstituted\u201d refers to being substituted with at least one substituent selected from the group consisting of a deuterium atom, halogen atom, \u2014OR 13  and \u2014S(O) n R 17 , R 13  represents a hydrogen atom, C 1 -C 7  acyl group or protecting group, R 17  represents a C 1 -C 6  alkyl group, and n represents 0, 1 or 2.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 88.0
- Lexical Diversity: 1.32432
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13809115', '13234514', '12604691', '11508322', '13503083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8081408558584054
- 35 USC 102 Novelty (BERT): 0.536016779314943
- Combined Prediction Score: 0.7809284482040592
- Mean Citation Score: 349.460232
- Max Citation Score: 362.0457
- Similarity Product: 298.62492311214214

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test